Pacific Biosciences of California, Inc. (PACB)
NASDAQ·Healthcare·Medical - Devices
$1.57
-1.26%
Mkt Cap $471.12M
Analyst Ratings
Buy
1
Hold
2
Sell
2
Price Target (12 analysts)
$2.74
Range $1.50 – $4.00
Implied Upside
+74.5%
Consensus $2.74 vs current $1.57